Cost of Adverse Events During Treatment with Everolimus Plus Exemestane or Single-Agent Chemotherapy in Patients with Advanced Breast Cancer
Abstract
Authors
M. Campone H. Yang E. Faust A. Kageleiry J. Signorovitch J. Zhang H. Gao